Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin
Authors:
- 1 December 2010
- journal article
- case report
- Published by Dustri-Verlag Dr. Karl Feistle in Int. Journal of Clinical Pharmacology and Therapeutics
- Vol. 48 (12) , 798-802
Abstract
Atorvastatin has been associated with liver injury. We reported here two cases of aminotransferases elevation within 12 h of low-dose atorvastatin therapy. Liver functions were fully recovered to the baseline level 11 days after discontinuation of atorvastatin treatment. The possible relative risk factors included advanced age, chronic and systemic diseases, and co-administration of cytochrome P450 3A (CYP3A) enzyme-dependent metabolic drugs or its inhibitors such as clopidogrel and diltiazem. No significant transaminase elevation was observed after switching to pravastatin. Thus, pravastatin might be safer than atorvastain in patients with chronic or systemic diseases, or with co-administration of CYP3A enzyme-dependent drugs.Keywords
This publication has 20 references indexed in Scilit:
- Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signalsHepatology, 2008
- Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trialHepatology, 2007
- Lipid-Lowering Agents That Cause Drug-Induced HepatotoxicityClinics in Liver Disease, 2007
- Atorvastatin associated liver diseaseDigestive and Liver Disease, 2006
- Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitorsThe American Journal of Cardiology, 2004
- Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet AggregationCirculation, 2003
- Atorvastatin-Induced Cholestatic Hepatitis in a Young Woman With Systemic Lupus ErythematosusArchives of internal medicine (1960), 1999
- Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallengeJournal of Clinical Epidemiology, 1993
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990